Sean Henderson
Urology · American Fork, UTNPI 1366753709
Payments from drug & device makers
What this record shows
This record is dominated by education: $16,104 of the $21,258 with a category attached, or 75.8%. Intuitive Surgical accounts for 79.3% of it on its own, with 27 other manufacturers making up the rest.
Across 169 payments — averaging $125.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$17K
- Procept Biorobotics Corporation$1K
- Boston Scientific$717
- Astellas Pharma US Inc$322
- Endo Pharmaceuticals Inc.$261
- AbbVie$255
- plus $1K from 22 others
What the payments were for
- Travel & lodging$1,4247%
- Food & beverage$3,73018%
- Education$16,10476%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 16 | $16,864 |
| Procept Biorobotics Corporation | 7 | $1,498 |
| Boston Scientific | 27 | $717 |
| Astellas Pharma US Inc | 15 | $322 |
| Endo Pharmaceuticals Inc. | 16 | $261 |
| AbbVie(2 entities) | 15 | $255 |
| Sumitomo Pharma America, Inc. | 8 | $188 |
| Coloplast | 6 | $147 |
| Pfizer | 8 | $141 |
| Johnson & Johnson(2 entities) | 7 | $105 |
| Endo USA, Inc. | 5 | $92 |
| Axonics, Inc. | 5 | $88 |
| Amgen | 4 | $80 |
| Antares Pharma, Inc. | 5 | $78 |
| Myriad Genetic Laboratories, Inc. | 4 | $60 |
| Bayer | 3 | $50 |
| Alnylam Pharmaceuticals Inc. | 3 | $46 |
| Laborie Medical Technologies Corp. | 1 | $46 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $43 |
| Travere Therapeutics, Inc. | 5 | $31 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
| Urogen Pharma, Inc. | 1 | $21 |
| Urovant Sciences Inc | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Teleflex LLC | 1 | $17 |
| Dendreon Pharmaceuticals LLC | 1 | $17 |
| Innovation Technologies Inc | 1 | $16 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$16,725
- AquaBeam Robotic System$1,395
How this compares
$21,258 in reported general payments places this provider in the 85th percentile of 96 urology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 47 | $36,282 |
| MyrbetriqMirabegron | 44 | $28,282 |
| Methenamine Hippurate | 59 | $3,744 |
| Solifenacin Succinate | 68 | $2,281 |
| Tamsulosin Hcl | 121 | $1,498 |
| Potassium Citrate ErPotassium Citrate | 13 | $1,213 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 244 | $1,036 |
| NitrofurantoinNitrofurantoin Macrocrystal | 14 | $560 |
| Finasteride | 50 | $473 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $367 |
| Cephalexin | 61 | $356 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 96 | $347 |
| Dutasteride | 12 | $170 |
| Tramadol Hcl | 63 | $156 |
| Ciprofloxacin Hcl | 33 | $155 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $188 | $36,28247 claims |
| Astellas Pharma US IncMyrbetriq | $322 | $28,28244 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 96 urology providers in Utah.
Other urology in American Fork
- Roscoe NelsonAmerican Fork$152K
- Nathan PursifullAmerican Fork$86K
- Stewart LandauAmerican Fork$27K
- Daniel CahoonAmerican Fork$18K
- Steven GangeSlc$1.5M
- William BrantSalt Lake City$290K
- Benjamin McCormickSalt Lake City$67K
- Richard MaternSalt Lake City$58K
- Akhil SajiSalt Lake City$49K
- Jeffrey SparenborgProvo$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.